Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Development and sale of software for the healthcare sector, along with associated hardware and the provision of related consultancy services.

BioStem's Q4-2024 revenue expected to rise 794% YoY, with full-year net revenue increasing 1,702%. Read why I'm bullish on ...